GF Fund Management’s Y-mAbs Therapeutics YMAB Stock Holding History

GF Fund Management’s Portfolio YMAB Stock Details YMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-1,111	Closed	-$5.01K	–	686
2025 Q2	$5.01K	Hold	1,111	–	–	﹤0.01%	624
2025 Q1	$4.92K	Buy	1,111 +171	+18%	+$993	﹤0.01%	625
2024 Q4	$7.36K	Buy	+940	New	+$11.4K	﹤0.01%	580

Other funds holding YMAB

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GF Fund Management's YMAB Position: Q3 2025 in Review

GF Fund Management sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 1,111 shares — an estimated $5.01K sold.

GF Fund Management first reported a position in YMAB in Q4 2024 and held it in 3 quarters. The position peaked at $7.36K in Q4 2024. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

GF Fund Management reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
GF Fund Management sold 1,111 Y-mAbs Therapeutics shares in Q3 2025, an estimated $5.01K.
GF Fund Management first reported a position in Y-mAbs Therapeutics in Q4 2024 and held it in 3 quarters.
GF Fund Management's Y-mAbs Therapeutics position peaked at $7.36K in Q4 2024.
2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.